Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: J Urol. 2015 Jan 10;193(6):2045–2051. doi: 10.1016/j.juro.2014.12.097

Table 3.

Adjusted odds of ED and/or LUTS at year 17 by quantitative CAN measures at DCCT closeout and EDIC year 16/17

Characteristic ED only (N=193) vs. No LUTS or ED (N=284) LUTS only (N=61) vs. No LUTS or ED (N=284) ED & LUTS (N=97) vs. No LUTS or ED (N=284)
CAN Measures* Odds ratio (95% CI)
At DCCT Closeout
 R-R Variation 0·96 (0·91–1·02) 0·98 (0·90–1·07) 1·11 (1·01–1·22)
 Valsalva Ratio 1·47 (1·10–1·96) 1·31 (0·90–1·92) 1·50 (1·01–2·21)
At EDIC Year 16/17
 R-R Variation 1·01 (0·94–1·08) 0·98 (0·89–1·08) 1·12 (1·01–1·25)
 Valsalva Ratio 1·43 (0·99–2·08) 0·90 (0·56–1·45) 2·11 (1·17–3·78)

Data are odds ratios (95% confidence intervals) from separate multivariable logistic regression models with ED/LUTS status as the dependent variable and CAN measures as the independent variables. The odds ratios were evaluated according to a 5-unit decrease in R-R Variation or a ½-unit decrease in Valsalva ratio. Adjustments were made for DCCT cohort assignment, DCCT/EDIC time-weighted HbA1c, DCCT/EDIC time-weighted systolic blood pressure, and the following EDIC year 17 characteristics: age, BMI, smoking status, drinking status, and any antihypertensive medication use.

*

Sample sizes vary based on availability of CAN data.